Searched over 200M research papers for "nad supplement"
10 papers analyzed
These studies suggest NAD supplementation may improve muscle activity, reduce inflammation, enhance metabolism, and offer potential benefits for age-related and metabolic disorders, though further research is needed to confirm optimal methods and target conditions.
20 papers analyzed
Nicotinamide adenine dinucleotide (NAD) is a critical coenzyme found in all living cells, playing a vital role in metabolic processes, including oxidative phosphorylation and DNA repair. As NAD levels decline with age, supplementation with NAD precursors has emerged as a promising strategy to combat age-related conditions and metabolic dysfunctions .
Nicotinamide riboside (NR) is a natural NAD precursor that has shown potential in enhancing oxidative metabolism and protecting against metabolic diseases. Studies have demonstrated that NR supplementation increases NAD levels, activates sirtuins (SIRT1 and SIRT3), and enhances mitochondrial function, thereby improving metabolic health and protecting against high-fat diet-induced obesity. In aged humans, NR supplementation has been shown to elevate the muscle NAD+ metabolome, reduce inflammatory cytokines, and downregulate energy metabolism pathways without altering mitochondrial bioenergetics.
Nicotinamide mononucleotide (NMN) is another NAD precursor that has shown beneficial effects in preclinical models. In a clinical trial involving overweight or obese postmenopausal women with prediabetes, NMN supplementation improved muscle insulin sensitivity and upregulated genes related to muscle remodeling, despite no detectable change in NAD+ content. This suggests that NMN may enhance metabolic function and insulin signaling in humans.
A systematic review of randomized clinical trials has indicated that NAD+ precursors, including nicotinic acid and nicotinamide, can significantly reduce BMI and increase adiponectin levels, although their effects on body weight and leptin were not significant. Another review highlighted the safety and effectiveness of NAD+ and NADH supplementation across various clinical conditions, including chronic fatigue syndrome, Parkinson's disease, and prediabetes. The studies reported improvements in quality of life, muscle insulin sensitivity, and reduced anxiety, with minimal side effects such as muscle pain and sleep disturbances.
A combination of nicotinamide riboside and pterostilbene (NRPT) has been shown to significantly increase NAD+ levels in a dose-dependent manner in healthy older adults, with no serious adverse events reported. Similarly, a combination of nicotinamide and D-ribose (RiaGev) was found to enhance the NAD+ metabolome, improve insulin sensitivity, and reduce fatigue in healthy middle-aged adults, demonstrating both efficacy and safety.
NAD supplementation has shown promise in treating age-related conditions such as psoriasis and enhancing skeletal muscle activity, although further trials are needed to determine the optimal methods and target conditions. The modulation of NAD+ levels has also been linked to improved health span and longevity, suggesting potential therapeutic applications in neurodegenerative diseases and other age-associated disorders .
The ability of NAD precursors to enhance oxidative metabolism and protect against metabolic dysfunctions positions them as valuable tools in managing obesity, diabetes, and related metabolic conditions. The observed improvements in insulin sensitivity and muscle remodeling further support their potential in metabolic health interventions .
NAD supplementation, particularly through precursors like NR and NMN, holds significant promise for improving metabolic health and combating age-related conditions. While current clinical evidence supports their efficacy and safety, further research is needed to optimize dosing, understand tissue-specific effects, and compare pharmacological methods with physiological interventions such as exercise and diet. As the field progresses, NAD supplementation could become a cornerstone in the therapeutic management of aging and metabolic diseases.
Most relevant research papers on this topic